1Department of Drug Quality Control and Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Wataniya Private University, Hama, Syria
2Department of Drug Quality Control and Pharmaceutical Chemistry (Drug synthesis), Faculty of Pharmacy, Al-Baath University, Homs, Syria
3Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Watanyia Private University, Hamah, Syria
Abstract
The use of Panax Ginseng (PG) products is continuously expanding around the world. The popular belief said herbal products are always “safe”, because of their natural source. However, evidence that indicates its quality before marketing is very limited. Although PG products have shown promising potential with efficacy, many of these products remain untested. This work aims to evaluate some quality aspects of PG products in regard with Qualitative, Quantitative (total Ginsenosiedes content (TGC)), microscopic, Loss On Drying (LOD) tests, and in comparison with PG crude plants. The qualitative test revealed the presence of flavonoids, alkaloids, glycosides, and saponins with the exception of tannins. The TGC ranged from (31.16 to102.58 mg/g). Microscopic findings revealed the presence of parenchyma cells with gelatinous content in product A. Moreover, Most of the products exceeded the reference limits for LOD. This process is becoming increasingly important, along with ‘quality control/assurance’, as a means of ensuring a consistent supply of high-quality herbal medicines